
Credprid G 1mg/500mg Tablet SR
Marketer
Lifecred Healthcare Pvt. Ltd.
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Credprid G 1mg/500mg Tablet SR
Diabetace G, a 1mg/500mg extended-release tablet, is an antidiabetic medication combining two agents to manage type 2 diabetes in adults. It effectively regulates blood glucose. Diabetace G should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your doctor.
Uses of Credprid G 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Credprid G 1mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Credprid G 1mg/500mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Credprid G 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Credprid G 1mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Credprid G 1mg/500mg Sustained-Release tablet should be taken with a meal.
How Credprid G 1mg/500mg Tablet SR works:
Each Credprid G 1mg/500mg extended-release tablet combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Credprid G 1mg/500mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Credprid G 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Credprid G tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Impaired driving is possible with abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Credprid G 1mg/500mg SR tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Credprid G 1mg/500mg SR tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Credprid G 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically recommended for those with mild to moderate hepatic dysfunction; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Credprid G 1mg/500mg Tablet SR :
Should you forget a dose of Credprid G 1mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Credprid G 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Medication |
